Each dose of JEspect in infants and children aged ≥2 months to <3 years is 0.25 mL.
There are no data to inform recommendations for booster doses in infants and children <18 years. Consider a booster if the child needs sustained protection.
≥9 months to <18 years
Imojev
1 dose
1–2 years after primary dose if ongoing risk of JE virus exposure
None
≥18 years
Imojev
1 dose
Not required
Seroprotective antibody levels persist in most adults 5 years after a single dose of Imojev.5
JEspect
2 doses (28 days apart)
1–2 years after primary dose if ongoing risk of JE virus exposure
Adults can receive an accelerated primary course of JEspect (2 × 0.5 mL doses, 7 days apart) if they are at imminent risk of exposure to JE virus.
